Melton L G, Dehmer G J, Gabriel D A
Department of Medicine, Center for Thrombosis and Hemostasis, University of North Carolina School of Medicine, Chapel Hill 27599-7305, USA.
Am J Cardiol. 1998 Aug 1;82(3):295-8. doi: 10.1016/s0002-9149(98)00330-0.
Although heparin and some radiographic contrast agents inhibit coagulation, thrombi can still form in their presence. The chemical environment in which a thrombus forms affects fibrin structure that may alter the ability of the thrombus to be lysed. Therefore, we assessed changes in fibrin structure in 13 patients referred for coronary angiography. Blood was obtained from the femoral vein, femoral artery, ascending aorta, left main coronary artery (LMCA), and coronary sinus (CS) before, during, and after coronary angiography was performed with iohexol. The number of fibrin monomers per fiber cross section was determined by turbidity measurements of fibrin gels formed from plasma samples. At baseline there was no difference in the number of fibrin monomers per fiber cross section in plasma gels generated from the different sampling sites. After iohexol administration, there was a significant decrease in the number of fibrin monomers per fiber cross section at the sampling sites ranging from - 13% to -25% compared with the respective baseline values with the largest change in the LMCA CS (51+/-16 to 38+/-15, p <0.025). Transcardiac (LM - CS value) changes in the number of fibrin monomers per fiber cross section were dependent on the timing of the sample collection in the CS. In 7 patients, the CS sample was collected approximately 2 minutes after injection of contrast material and there was no transcardiac difference. When the CS sample was obtained during contrast injection (n=6) a large transcardiac change occurred (44+/-10 to 32+/-14, p=0.01). These data show transient changes in fibrin structure during coronary angiography with iohexol. The thinner fibers formed in the presence of iohexol were more resistant to fibrinolysis.
尽管肝素和一些放射造影剂会抑制凝血,但在它们存在的情况下血栓仍可能形成。血栓形成的化学环境会影响纤维蛋白结构,这可能会改变血栓被溶解的能力。因此,我们评估了13例因冠状动脉造影而转诊患者的纤维蛋白结构变化。在使用碘海醇进行冠状动脉造影之前、期间和之后,从股静脉、股动脉、升主动脉、左冠状动脉主干(LMCA)和冠状窦(CS)采集血液。通过对血浆样本形成的纤维蛋白凝胶进行浊度测量来确定每个纤维横截面的纤维蛋白单体数量。在基线时,不同采样部位产生的血浆凝胶中每个纤维横截面的纤维蛋白单体数量没有差异。注射碘海醇后,与各自的基线值相比,采样部位每个纤维横截面的纤维蛋白单体数量显著减少,减少幅度在-13%至-25%之间,其中LMCA - CS的变化最大(从51±16降至38±15,p<0.025)。每个纤维横截面的纤维蛋白单体数量的跨心脏(LM - CS值)变化取决于在CS采集样本的时间。在7例患者中,在注射造影剂后约2分钟采集CS样本,没有跨心脏差异。当在注射造影剂期间采集CS样本时(n = 6),出现了较大的跨心脏变化(从44±10降至32±14,p = 0.01)。这些数据显示了在使用碘海醇进行冠状动脉造影期间纤维蛋白结构的短暂变化。在碘海醇存在下形成的较细纤维对纤维蛋白溶解更具抵抗力。